208 related articles for article (PubMed ID: 36932129)
21. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management.
Shanbhogue AK; Prasad SR; Takahashi N; Vikram R; Sahani DV
Radiology; 2011 Mar; 258(3):673-93. PubMed ID: 21339346
[TBL] [Abstract][Full Text] [Related]
22. Fibrolamellar hepatocellular carcinoma.
Liu S; Chan KW; Wang B; Qiao L
Am J Gastroenterol; 2009 Oct; 104(10):2617-24; quiz 2625. PubMed ID: 19638962
[TBL] [Abstract][Full Text] [Related]
23. DNA ploidy of fibrolamellar hepatocellular carcinoma by image analysis.
Orsatti G; Greenberg PD; Rolfes DB; Ishak KG; Paronetto F
Hum Pathol; 1994 Sep; 25(9):936-9. PubMed ID: 8088770
[TBL] [Abstract][Full Text] [Related]
24. Hyperammonemic encephalopathy: a rare presentation of fibrolamellar hepatocellular carcinoma.
Sethi S; Tageja N; Singh J; Arabi H; Dave M; Badheka A; Revankar S
Am J Med Sci; 2009 Dec; 338(6):522-4. PubMed ID: 20010160
[TBL] [Abstract][Full Text] [Related]
25. Multiomic analysis of microRNA-mediated regulation reveals a proliferative axis involving miR-10b in fibrolamellar carcinoma.
Francisco AB; Kanke M; Massa AP; Dinh TA; Sritharan R; Vakili K; Bardeesy N; Sethupathy P
JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35482409
[TBL] [Abstract][Full Text] [Related]
26.
Kastenhuber ER; Lalazar G; Houlihan SL; Tschaharganeh DF; Baslan T; Chen CC; Requena D; Tian S; Bosbach B; Wilkinson JE; Simon SM; Lowe SW
Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13076-13084. PubMed ID: 29162699
[TBL] [Abstract][Full Text] [Related]
27. Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.
Lalazar G; Simon SM
Semin Liver Dis; 2018 Feb; 38(1):51-59. PubMed ID: 29471565
[TBL] [Abstract][Full Text] [Related]
28. Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation.
McLarney JK; Rucker PT; Bender GN; Goodman ZD; Kashitani N; Ros PR
Radiographics; 1999; 19(2):453-71. PubMed ID: 10194790
[TBL] [Abstract][Full Text] [Related]
29. A genomic case study of mixed fibrolamellar hepatocellular carcinoma.
Griffith OL; Griffith M; Krysiak K; Magrini V; Ramu A; Skidmore ZL; Kunisaki J; Austin R; McGrath S; Zhang J; Demeter R; Graves T; Eldred JM; Walker J; Larson DE; Maher CA; Lin Y; Chapman W; Mahadevan A; Miksad R; Nasser I; Hanto DW; Mardis ER
Ann Oncol; 2016 Jun; 27(6):1148-1154. PubMed ID: 27029710
[TBL] [Abstract][Full Text] [Related]
30. Loss of the orphan nuclear receptor SHP is more pronounced in fibrolamellar carcinoma than in typical hepatocellular carcinoma.
Wilczek E; Szparecki G; Lukasik D; Koperski L; Winiarska M; Wilczynski GM; Wasiutynski A; Gornicka B
PLoS One; 2012; 7(1):e30944. PubMed ID: 22292081
[TBL] [Abstract][Full Text] [Related]
31. DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma.
Vyas M; Hechtman JF; Zhang Y; Benayed R; Yavas A; Askan G; Shia J; Klimstra DS; Basturk O
Mod Pathol; 2020 Apr; 33(4):648-656. PubMed ID: 31676785
[TBL] [Abstract][Full Text] [Related]
32. Fibrolamellar hepatocellular carcinoma presenting as cholestatic jaundice: An unusual presentation of a rare disease.
Singh A; Goyal S; Mehta V; Kakkar C; Narang V; Sood A
Indian J Pathol Microbiol; 2023; 66(2):385-387. PubMed ID: 37077092
[TBL] [Abstract][Full Text] [Related]
33. Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features.
Malouf GG; Tahara T; Paradis V; Fabre M; Guettier C; Yamazaki J; Long H; Lu Y; Raynal NJ; Jelinek J; Mouawad R; Khayat D; Brugières L; Raymond E; Issa JP
Epigenetics; 2015; 10(9):872-81. PubMed ID: 26224146
[TBL] [Abstract][Full Text] [Related]
34. Infrequent chromosome allele loss in fibrolamellar carcinoma.
Ding SF; Delhanty JD; Bowles L; Dooley JS; Wood CB; Habib NA
Br J Cancer; 1993 Feb; 67(2):244-6. PubMed ID: 8094289
[TBL] [Abstract][Full Text] [Related]
35. Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study.
Short SS; Kastenberg ZJ; Wei G; Bondoc A; Dasgupta R; Tiao GM; Watters E; Heaton TE; Lotakis D; La Quaglia MP; Murphy AJ; Davidoff AM; Mansfield SA; Langham MR; Lautz TB; Superina RA; Ott KC; Malek MM; Morgan KM; Kim ES; Zamora A; Lascano D; Roach J; Murphy JT; Rothstein DH; Vasudevan SA; Whitlock R; Lal DR; Hallis B; Bütter A; Baertschiger RM; Lapidus-Krol E; Putra J; Tracy ER; Aldrink JH; Apfeld J; Le HD; Park KY; Rich BS; Glick RD; Fialkowski EA; Utria AF; Meyers RL; Riehle KJ
Cancer; 2022 Jul; 128(14):2786-2795. PubMed ID: 35561331
[TBL] [Abstract][Full Text] [Related]
36. [A histopathologic comparative study of European cases of fibrolamellar carcinoma and Japanese cases of sclerosing hepatocellular carcinoma].
Haratake J; Horie A
Gan No Rinsho; 1989 Jun; 35(7):793-8. PubMed ID: 2544750
[TBL] [Abstract][Full Text] [Related]
37. [A particular hepatocellular carcinoma combining the ordinary and the fibrolamellar variant].
Zermani R; Charfi L; Kourda N; Farah F; Rammeh S; Trabelsi O; Zaouch A; Ben Jilani S
Tunis Med; 2005 Jul; 83(7):419-21. PubMed ID: 16220700
[TBL] [Abstract][Full Text] [Related]
38. Single-Cell RNA Sequencing Identifies Yes-Associated Protein 1-Dependent Hepatic Mesothelial Progenitors in Fibrolamellar Carcinoma.
Jewell ML; Gibson JR; Guy CD; Hyun J; Du K; Oh SH; Premont RT; Hsu DS; Ribar T; Gregory SG; Diehl AME
Am J Pathol; 2020 Jan; 190(1):93-107. PubMed ID: 31669305
[TBL] [Abstract][Full Text] [Related]
39. Fibrolamellar carcinoma of the liver: CT, ultrasound and angiography. Case report.
Bedi DG; Kumar R; Morettin LB; Gourley K
Eur J Radiol; 1988 May; 8(2):109-12. PubMed ID: 2838279
[TBL] [Abstract][Full Text] [Related]
40. Cytologic features of fibrolamellar carcinoma with mucin production: a rare variant of combined hepatocellular-cholangiocarcinoma.
Rosa M; Mohammadi A
Diagn Cytopathol; 2014 May; 42(5):431-5. PubMed ID: 23008149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
